chr11-123754434-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005188.1(OR6X1):āc.85A>Gā(p.Ile29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,613,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005188.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6X1 | NM_001005188.1 | c.85A>G | p.Ile29Val | missense_variant | 1/1 | ENST00000327930.3 | NP_001005188.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6X1 | ENST00000327930.3 | c.85A>G | p.Ile29Val | missense_variant | 1/1 | NM_001005188.1 | ENSP00000333724 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251280Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135860
GnomAD4 exome AF: 0.000108 AC: 158AN: 1461810Hom.: 0 Cov.: 32 AF XY: 0.000118 AC XY: 86AN XY: 727194
GnomAD4 genome AF: 0.000118 AC: 18AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.85A>G (p.I29V) alteration is located in exon 1 (coding exon 1) of the OR6X1 gene. This alteration results from a A to G substitution at nucleotide position 85, causing the isoleucine (I) at amino acid position 29 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at